Sensorcaine is a brand name of bupivacaine, approved by the FDA in the following formulation(s):
SENSORCAINE (bupivacaine hydrochloride - injectable; injection)
Manufacturer: APP PHARMS
Approved Prior to Jan 1, 1982
Strength(s): 0.25% [AP], 0.5% [AP], 0.75% [AP]
Has a generic version of Sensorcaine been approved?
Yes. The following products are equivalent to Sensorcaine:
bupivacaine hydrochloride injectable; injection
Manufacturer: HOSPIRA
Approved Prior to Jan 1, 1982
Strength(s): 0.25% [AP], 0.5% [AP], 0.75% [AP]
Manufacturer: HOSPIRA
Approval date: February 17, 1986
Strength(s): 0.5% [AP]
Manufacturer: HOSPIRA
Approval date: February 17, 1987
Strength(s): 0.25% [AP], 0.25% [AP]
Manufacturer: HOSPIRA
Approval date: March 3, 1987
Strength(s): 0.25% [AP], 0.5% [AP], 0.5% [AP], 0.75% [AP], 0.75% [AP]
Manufacturer: SAGENT STRIDES
Approval date: October 18, 2011
Strength(s): 0.25% [AP], 0.5% [AP]
BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE (bupivacaine hydrochloride injectable; injection)
Manufacturer: INTL MEDICATED
Approval date: January 9, 2002
Strength(s): 0.25% [AP], 0.5% [AP], 0.75% [AP]
Manufacturer: SAGENT STRIDES
Approval date: October 18, 2011
Strength(s): 0.25% [AP], 0.5% [AP], 0.75% [AP]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Sensorcaine. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Sensorcaine.
See also...
- Sensorcaine Solution Consumer Information (Wolters Kluwer)
- Sensorcaine Consumer Information (Cerner Multum)
- Bupivacaine Solution Consumer Information (Wolters Kluwer)
- Bupivacaine in Dextrose Solution Consumer Information (Wolters Kluwer)
- Bupivacaine Consumer Information (Cerner Multum)
- Bupivacaine Hydrochloride AHFS DI Monographs (ASHP)
No comments:
Post a Comment